• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过病毒展示、半随机肽文库筛选靶向前列腺特异性膜抗原的腺病毒。

Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening.

机构信息

The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

出版信息

Cancer Res. 2010 Dec 1;70(23):9549-53. doi: 10.1158/0008-5472.CAN-10-1760. Epub 2010 Jul 29.

DOI:10.1158/0008-5472.CAN-10-1760
PMID:20670952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2995819/
Abstract

The convergence of phage-displayed peptide libraries and recombinant viral vectors launched a promising new direction in targeted viral gene therapeutics, but the translation of targeting peptides to functional cancer therapeutic agents has been challenging. Here, we report progress in developing a successful strategy to optimize targeted viral infection through adenovirus-displayed, semirandom peptide libraries. A phage-derived peptide targeting the prostate-specific membrane antigen (PSMA) was genetically incorporated into the adenoviral capsid Fiber protein and flanked by random peptide cassettes. The resulting adenovirus library was biopanned against PSMA-expressing cells and tumors to identify a PSMA-retargeted adenovirus. While the initial peptide alone could not target viral infection, the selected virus preferentially infects PSMA-expressing cells through the targeting peptide and infects LNCaP tumors after intravenous injection. Our results indicate that virus-displayed, semirandom peptide libraries can be used to optimize targeting infection. This approach represents a novel principle for developing targeted agents in a variety of disease models.

摘要

噬菌体展示肽文库和重组病毒载体的融合为靶向病毒基因治疗开辟了一个有前途的新方向,但将靶向肽转化为功能性癌症治疗剂一直具有挑战性。在这里,我们报告了在开发通过腺病毒展示的半随机肽文库来优化靶向病毒感染的成功策略方面的进展。一种针对前列腺特异性膜抗原 (PSMA) 的噬菌体衍生肽被基因整合到腺病毒衣壳纤维蛋白中,并被随机肽盒侧翼。由此产生的腺病毒文库针对表达 PSMA 的细胞和肿瘤进行生物淘选,以鉴定出一种针对 PSMA 的重定向腺病毒。虽然最初的肽本身不能靶向病毒感染,但所选病毒通过靶向肽优先感染表达 PSMA 的细胞,并在静脉注射后感染 LNCaP 肿瘤。我们的结果表明,病毒展示的半随机肽文库可用于优化靶向感染。这种方法为在各种疾病模型中开发靶向药物提供了一个新的原则。

相似文献

1
Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening.通过病毒展示、半随机肽文库筛选靶向前列腺特异性膜抗原的腺病毒。
Cancer Res. 2010 Dec 1;70(23):9549-53. doi: 10.1158/0008-5472.CAN-10-1760. Epub 2010 Jul 29.
2
A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity.一种二聚体肽,它能选择性地结合前列腺特异性膜抗原并抑制其酶活性。
Cancer Res. 2006 Sep 15;66(18):9171-7. doi: 10.1158/0008-5472.CAN-06-1520.
3
Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector.基于树突状细胞的 PSMA 免疫疗法用于前列腺癌的 CD40 靶向腺病毒载体。
PLoS One. 2012;7(10):e46981. doi: 10.1371/journal.pone.0046981. Epub 2012 Oct 8.
4
Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.前列腺特异性膜抗原(PSMA)是体外腺病毒转导前列腺癌的组织特异性靶点。
Prostate. 2005 Feb 15;62(3):253-9. doi: 10.1002/pros.20150.
5
Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.具有对前列腺癌的两种不同生物标志物(胃泌素释放肽受体/前列腺特异性膜抗原)亲和力的新型二价靶向载体——铜-64放射性标记的[DUPA-6-氨基己酸-(NODAGA)-5-氨基戊酸-蛙皮素(7-14)NH2]的合成与生物学评价
Nucl Med Biol. 2014 Apr;41(4):355-63. doi: 10.1016/j.nucmedbio.2014.01.001. Epub 2014 Jan 10.
6
Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.通过PSES增强子控制腺病毒E1a和E4基因表达进行前列腺癌的基因治疗
Cancer Res. 2005 Mar 1;65(5):1941-51. doi: 10.1158/0008-5472.CAN-04-3666.
7
Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen.与前列腺特异性膜抗原细胞外部分结合的二硫键约束肽。
Mol Cancer Ther. 2004 May;3(5):597-603.
8
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.用于治疗前列腺癌的前列腺特异性膜抗原重新靶向麻疹病毒疗法。
Prostate. 2009 Jul 1;69(10):1128-41. doi: 10.1002/pros.20962.
9
Discovery of PSMA-specific peptide ligands for targeted drug delivery.用于靶向药物递送的PSMA特异性肽配体的发现。
Int J Pharm. 2016 Nov 20;513(1-2):138-147. doi: 10.1016/j.ijpharm.2016.08.048. Epub 2016 Aug 28.
10
Ad5/35E1aPSESE4: A novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA/PSMA transcription regulatory elements.Ad5/35E1aPSESE4:一种利用由前列腺特异性抗原(PSA)/前列腺特异性膜抗原(PSMA)转录调控元件控制的具有复制能力的腺病毒标记循环前列腺肿瘤细胞的新方法。
Cancer Lett. 2016 Mar 1;372(1):57-64. doi: 10.1016/j.canlet.2015.12.018. Epub 2015 Dec 23.

引用本文的文献

1
Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity.溶瘤腺病毒:提高靶向性和特异性的策略
Cancers (Basel). 2020 Jun 9;12(6):1504. doi: 10.3390/cancers12061504.
2
Retargeting adenoviruses for therapeutic applications and vaccines.靶向腺病毒用于治疗应用和疫苗。
FEBS Lett. 2020 Jun;594(12):1918-1946. doi: 10.1002/1873-3468.13731. Epub 2020 Feb 3.
3
Gene Therapy Leaves a Vicious Cycle.基因治疗导致恶性循环。
Front Oncol. 2019 Apr 24;9:297. doi: 10.3389/fonc.2019.00297. eCollection 2019.
4
Retargeted and detargeted adenovirus for gene delivery to the muscle.靶向和非靶向腺病毒用于肌肉基因递送。
Virology. 2018 Jan 15;514:118-123. doi: 10.1016/j.virol.2017.10.005. Epub 2017 Nov 22.
5
Recent advances in genetic modification of adenovirus vectors for cancer treatment.用于癌症治疗的腺病毒载体基因改造的最新进展。
Cancer Sci. 2017 May;108(5):831-837. doi: 10.1111/cas.13228. Epub 2017 May 7.
6
Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.MRI 分子成像用前列腺特异性膜抗原靶向蛋白对比剂。
Nanoscale. 2016 Jul 7;8(25):12668-82. doi: 10.1039/c5nr09071g. Epub 2016 Mar 10.
7
A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.一种通过基于腺病毒的报告载体检测有活力和组织特异性循环肿瘤细胞的新方法。
Prostate. 2014 Sep;74(13):1286-1296. doi: 10.1002/pros.22845. Epub 2014 Jul 25.
8
Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.通过将遗传配体插入不同的衣壳支架,腺病毒在体外和体内将癌症标志物EphA2用作受体。
PLoS One. 2014 Apr 23;9(4):e95723. doi: 10.1371/journal.pone.0095723. eCollection 2014.
9
Development of peritoneal tumor-targeting vector by in vivo screening with a random peptide-displaying adenovirus library.利用随机肽展示腺病毒文库进行体内筛选,开发腹膜肿瘤靶向载体。
PLoS One. 2012;7(9):e45550. doi: 10.1371/journal.pone.0045550. Epub 2012 Sep 20.
10
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.2-(3-{1-羧基-5-[(6-[18F]氟吡啶-3-羰基)-氨基]-戊基}-脲基)-戊二酸,[18F]DCFPyL,一种用于前列腺癌的 PSMA 基 PET 成像剂。
Clin Cancer Res. 2011 Dec 15;17(24):7645-53. doi: 10.1158/1078-0432.CCR-11-1357. Epub 2011 Oct 31.

本文引用的文献

1
Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.用 p21/Waf-1 shRNAs 武装 CRAds:新一代溶瘤腺病毒。
Cancer Gene Ther. 2010 Aug;17(8):585-97. doi: 10.1038/cgt.2010.15. Epub 2010 May 7.
2
Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus.六邻体修饰的溶瘤腺病毒扩大了抗癌治疗窗口。
Mol Ther. 2009 Dec;17(12):2121-30. doi: 10.1038/mt.2009.217. Epub 2009 Sep 15.
3
Systemic delivery of therapeutic viruses.治疗性病毒的全身递送。
Curr Opin Mol Ther. 2009 Aug;11(4):411-20.
4
Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver.多种冗余且协同的机制控制着血液中腺病毒在肝脏的潴留。
Mol Ther. 2009 Apr;17(4):675-84. doi: 10.1038/mt.2008.307. Epub 2009 Feb 17.
5
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.基于放射性卤化前列腺特异性膜抗原(PSMA)的脲类作为前列腺癌的成像剂。
J Med Chem. 2008 Dec 25;51(24):7933-43. doi: 10.1021/jm801055h.
6
Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver.腺病毒血清型5六邻体高变区5的替换消除了血液因子结合并限制了基因向肝脏的转移。
Mol Ther. 2008 Aug;16(8):1474-80. doi: 10.1038/mt.2008.132. Epub 2008 Jun 17.
7
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo.腺病毒5型六邻体蛋白对于病毒在体内感染肝细胞至关重要。
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5483-8. doi: 10.1073/pnas.0711757105. Epub 2008 Apr 7.
8
Adenovirus serotype 5 hexon mediates liver gene transfer.腺病毒5型六邻体介导肝脏基因转移。
Cell. 2008 Feb 8;132(3):397-409. doi: 10.1016/j.cell.2008.01.016.
9
A novel method for generating and screening peptides and libraries displayed on adenovirus fiber.一种用于生成和筛选展示在腺病毒纤维上的肽段及文库的新方法。
Nucleic Acids Res. 2007;35(20):e138. doi: 10.1093/nar/gkm914. Epub 2007 Oct 26.
10
Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.通过纤维纽扣上的随机肽展示直接选择靶向腺病毒载体。
Gene Ther. 2007 Oct;14(20):1448-60. doi: 10.1038/sj.gt.3303007. Epub 2007 Aug 16.